Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
90 participants
INTERVENTIONAL
2018-12-31
2020-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Feasibility Study of a Post-hospitalization Self-rehabilitation Program for Elderly Suffering of Sarcopenia
NCT03834103
Claudication Evaluation During Rowing ExerciseS
NCT02833597
The Prevalence of Malnutrition and Sarcopenia in Swiss Rehabilitation Settings
NCT05639985
Multi-component Real-time Remote Rehabilitation in Sarcopenia
NCT06937073
Lower Limb Resistance Training in Older Inpatients
NCT02141126
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention : Physical rehabilitation
The Arm "Physical rehabilitation" will benefit from the implementation of the "Loss of Mobility Prevention" program set up in the Department of Aging Medicine of the Center Hospitalier Lyon Sud (CHLS) of Pr BONNEFOY.
Physical rehabilitation
It will benefit from an initial and final geriatric assessment, an initial dietary balance and a personalized treatment in physical activities adapted for 3 months by an Educator in Adapted Physical Activities.
Control : optimized medical treatment
The Arm "Optimized medical treatment" will not benefit from the implementation of the "Loss of Mobility Prevention" program.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Physical rehabilitation
It will benefit from an initial and final geriatric assessment, an initial dietary balance and a personalized treatment in physical activities adapted for 3 months by an Educator in Adapted Physical Activities.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age over 70 years
* CKD stage 3B, 4 or 5 or a DFG \<45ml / min according to CKD-EPI formula
* an SPPB (Short Physical Performance Battery test )\<10
* having received a complete and loyal information and having given his written and informed consent.
* ability to rehabilitate
* General condition not compatible for the realization of physical rehabilitation
* Patient protected under the terms of the law.
* Inability to respect the follow-up of the study for geographical, social or psychological reasons.
* depression or other psychiatric disorder
* Refusal to participate in the study
* Absence of affiliation to the social security system
* Subject in a exclusion period of an other study
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Service de Médecine du vieillissement, soins de suite et de rééducation, Centre Hospitalier Lyon SUd
Pierre-Bénite, , France
Service de Néphrologie, Centre Hospitalier Lyon Sud
Pierre-Bénite, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
69HCL17_0598
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.